Management of Post-Treatment Lyme Disease

Understanding Post-Treatment Serology

A positive IgM test after treatment of Lyme disease does not indicate treatment failure or active infection and should not prompt additional antibiotic therapy in the absence of objective clinical signs of disease activity, as recommended by the American College of Rheumatology 1, 2
IgM antibodies commonly persist for months or years after successful treatment of Lyme disease, and their presence alone does not indicate ongoing infection, according to the Infectious Diseases Society of America 3

Evidence of persistent infection or treatment failure requires objective signs of disease activity, such as arthritis with documented joint swelling and effusion, as recommended by the American College of Rheumatology 1, 2, 4
Meningitis with CSF abnormalities, neuropathy with objective neurologic findings, and carditis with documented conduction abnormalities are also indicators of active disease, according to the American College of Rheumatology 1

For patients with persistent nonspecific symptoms but lacking objective evidence of reinfection or treatment failure, additional antibiotic therapy is strongly not recommended, as stated by the IDSA/AAN/ACR 2020 guidelines with moderate-quality evidence 1, 2, 5
Treatment failure rate with appropriate initial therapy is approximately 1%, according to the Infectious Diseases Society of America 3

Only proceed with additional treatment if there are documented objective findings, such as partial response to initial treatment, which may require observation or a second 28-day course of oral antibiotics, as recommended by the American College of Rheumatology 1, 2, 4
No or minimal response to initial treatment may require a 2-4 week course of IV ceftriaxone, according to the American College of Rheumatology 1, 2, 4

Never treat based on positive IgM serology alone without objective clinical findings, as this leads to unnecessary antibiotic exposure and potential harm, as warned by the American College of Rheumatology 1, 2
Do not confuse persistent antibodies with persistent infection, as serologic testing cannot distinguish between past treated infection and active disease, according to the Infectious Diseases Society of America 3
Recognize that most patients respond to initial treatment, with approximately 99% of appropriately treated patients achieving cure, as stated by the Infectious Diseases Society of America 3